drugset / Trial / NCT00137462

Lipitor Trial To Study The Effect Of Torcetrpib/Atorvastatin To Atorvastatin Alone.

NCT00137462 ↗

Phase 3 Completed 900 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

The Torcetrapib project was terminated on December 2, 2006 due to safety findings. To look at various lipids in the blood of people with Fredrickson Type IIa and Type IIb mixed dyslipidemias

Timeline

Start
2004-11
Primary completion
—
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule — —
Subject torcetrapib Small molecule — Oral

Indications